Biotech | October 22, 2021
Rakuten Medical partners with Karkinos Healthcare to expand novel cancer care in India
This strategic collaboration will enable continued innovation in cancer care
This strategic collaboration will enable continued innovation in cancer care
Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
The trial met the primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib
Subscribe To Our Newsletter & Stay Updated
